|
Volumn 25, Issue 23, 2007, Pages 3552-
|
Chemotherapy administration for ovarian cancer by gynecologic oncologists and medical oncologists [4]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BEVACIZUMAB;
CARBOPLATIN;
PACLITAXEL;
CANCER CHEMOTHERAPY;
CANCER MORTALITY;
CANCER PREVENTION;
CANCER SURGERY;
CANCER SURVIVAL;
CANCER THERAPY;
COMBINATION CHEMOTHERAPY;
CYTOREDUCTIVE SURGERY;
HEALTH PRACTITIONER;
HUMAN;
LETTER;
MEDICAL EDUCATION;
MEDICAL PRACTICE;
MEDICAL PROFESSION;
MEDICAL SOCIETY;
OVARY CANCER;
PATIENT CARE;
PRIORITY JOURNAL;
ANTINEOPLASTIC AGENTS;
FEMALE;
GYNECOLOGY;
HUMANS;
MEDICAL ONCOLOGY;
OVARIAN NEOPLASMS;
SPECIALTIES, MEDICAL;
TREATMENT OUTCOME;
|
EID: 34548173956
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2007.12.2960 Document Type: Letter |
Times cited : (2)
|
References (4)
|